Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $2.79 and traded as high as $2.99. Evotec shares last traded at $2.99, with a volume of 24,629 shares.
Evotec Price Performance
The stock has a fifty day moving average of $2.79 and a two-hundred day moving average of $3.14. The stock has a market cap of $987.36 million, a price-to-earnings ratio of 7.29 and a beta of 0.98. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53.
About Evotec
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
See Also
- Five stocks we like better than Evotec
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
